Ovarian sensitivity to human gonadotrophins in women with amenorrhoea after oral contraceptive treatment.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000568:Amenorrhea / Q000139:chemically induced / Q000188:drug therapy*; D001831:Body Temperature; D003276:Contraceptives, Oral / Q000009:adverse effects; D004967:Estrogens / Q000097:blood / Q000652:urine; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000652:urine; D006062:Gonadotropins / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood / Q000652:urine; D010053:Ovary / Q000187:drug effects*; D010060:Ovulation; D011276:Pregnanediol / Q000652:urine; D011374:Progesterone / Q000097:blood
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D003276:Contraceptives, Oral; D004967:Estrogens; D006062:Gonadotropins; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D011276:Pregnanediol